First successful hemoadsorption using CytoSorb® in a septic pediatric patient in Kazakhstan: A case report

Vitaliy Sazonov; Askhat Saparov; Zaure Tobylbaeva; Samat Isakov; Almat Bekpan; Darkhan Autalipov; Bakhyt Muratbekova; Zhazira Manaybekova; Vitaliy Anikin

doi:10.1177/0391398818819953

First successful hemoadsorption using CytoSorb^® in a septic pediatric patient in Kazakhstan: A case report

Vitaliy Sazonov, Askhat Saparov, Zaure Tobylbaeva, Samat Isakov, Almat Bekpan, Darkhan Autalipov, Bakhyt Muratbekova, Zhazira Manaybekova, Vitaliy Anikin

Nazarbayev University

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Purpose: For the first time in Kazakhstan, we have used a combined extracorporeal support, by including the CytoSorb system in a continuous veno-venous hemofiltration system in an 8-month-old patient with a body weight of 5600 g. Results: The CytoSorb therapy session resulted in a reduction of inflammation markers IL-6, S100, procalcitonin, and C-reactive protein. Simultaneously, the level of transaminases, creatine kinase, and troponin were normalized, by the end of the session patient hemodynamics were stable and there was no need for vasopressors, acid–base balance was maintained, and the patient was weaned from mechanical ventilation to spontaneous breathing. Conclusion: Treatment using the CytoSorb device was safe and well-tolerated in a pediatric patient and has proven its practical value as an adjuvant therapy for sepsis in pediatric patient populations.

Original language	English
Pages (from-to)	315-317
Number of pages	3
Journal	International Journal of Artificial Organs
Volume	42
Issue number	6
DOIs	https://doi.org/10.1177/0391398818819953
Publication status	Published - Jun 1 2019

Keywords

chronic tracheal cannulation
CytoSorb
hemoadsorption
pediatric population
pediatric sepsis
pneumonia
Sepsis
septic shock
severe laryngeal stenosis

ASJC Scopus subject areas

Bioengineering
Medicine (miscellaneous)
Biomaterials
Biomedical Engineering

Access to Document

10.1177/0391398818819953

Fingerprint Dive into the research topics of 'First successful hemoadsorption using CytoSorb<sup>®</sup> in a septic pediatric patient in Kazakhstan: A case report'. Together they form a unique fingerprint.

Cite this

First successful hemoadsorption using CytoSorb^® in a septic pediatric patient in Kazakhstan : A case report. / Sazonov, Vitaliy; Saparov, Askhat; Tobylbaeva, Zaure; Isakov, Samat; Bekpan, Almat; Autalipov, Darkhan; Muratbekova, Bakhyt; Manaybekova, Zhazira; Anikin, Vitaliy.

In: International Journal of Artificial Organs, Vol. 42, No. 6, 01.06.2019, p. 315-317.

Research output: Contribution to journal › Article › peer-review

@article{453febf77ff749d08085899894be0a85,

title = "First successful hemoadsorption using CytoSorb{\textregistered} in a septic pediatric patient in Kazakhstan: A case report",

abstract = "Purpose: For the first time in Kazakhstan, we have used a combined extracorporeal support, by including the CytoSorb system in a continuous veno-venous hemofiltration system in an 8-month-old patient with a body weight of 5600 g. Results: The CytoSorb therapy session resulted in a reduction of inflammation markers IL-6, S100, procalcitonin, and C-reactive protein. Simultaneously, the level of transaminases, creatine kinase, and troponin were normalized, by the end of the session patient hemodynamics were stable and there was no need for vasopressors, acid–base balance was maintained, and the patient was weaned from mechanical ventilation to spontaneous breathing. Conclusion: Treatment using the CytoSorb device was safe and well-tolerated in a pediatric patient and has proven its practical value as an adjuvant therapy for sepsis in pediatric patient populations.",

keywords = "chronic tracheal cannulation, CytoSorb, hemoadsorption, pediatric population, pediatric sepsis, pneumonia, Sepsis, septic shock, severe laryngeal stenosis",

author = "Vitaliy Sazonov and Askhat Saparov and Zaure Tobylbaeva and Samat Isakov and Almat Bekpan and Darkhan Autalipov and Bakhyt Muratbekova and Zhazira Manaybekova and Vitaliy Anikin",

year = "2019",

month = jun,

day = "1",

doi = "10.1177/0391398818819953",

language = "English",

volume = "42",

pages = "315--317",

journal = "International Journal of Artificial Organs",

issn = "0391-3988",

publisher = "Wichtig Publishing",

number = "6",

}

TY - JOUR

T1 - First successful hemoadsorption using CytoSorb® in a septic pediatric patient in Kazakhstan

T2 - A case report

AU - Sazonov, Vitaliy

AU - Saparov, Askhat

AU - Tobylbaeva, Zaure

AU - Isakov, Samat

AU - Bekpan, Almat

AU - Autalipov, Darkhan

AU - Muratbekova, Bakhyt

AU - Manaybekova, Zhazira

AU - Anikin, Vitaliy

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Purpose: For the first time in Kazakhstan, we have used a combined extracorporeal support, by including the CytoSorb system in a continuous veno-venous hemofiltration system in an 8-month-old patient with a body weight of 5600 g. Results: The CytoSorb therapy session resulted in a reduction of inflammation markers IL-6, S100, procalcitonin, and C-reactive protein. Simultaneously, the level of transaminases, creatine kinase, and troponin were normalized, by the end of the session patient hemodynamics were stable and there was no need for vasopressors, acid–base balance was maintained, and the patient was weaned from mechanical ventilation to spontaneous breathing. Conclusion: Treatment using the CytoSorb device was safe and well-tolerated in a pediatric patient and has proven its practical value as an adjuvant therapy for sepsis in pediatric patient populations.

AB - Purpose: For the first time in Kazakhstan, we have used a combined extracorporeal support, by including the CytoSorb system in a continuous veno-venous hemofiltration system in an 8-month-old patient with a body weight of 5600 g. Results: The CytoSorb therapy session resulted in a reduction of inflammation markers IL-6, S100, procalcitonin, and C-reactive protein. Simultaneously, the level of transaminases, creatine kinase, and troponin were normalized, by the end of the session patient hemodynamics were stable and there was no need for vasopressors, acid–base balance was maintained, and the patient was weaned from mechanical ventilation to spontaneous breathing. Conclusion: Treatment using the CytoSorb device was safe and well-tolerated in a pediatric patient and has proven its practical value as an adjuvant therapy for sepsis in pediatric patient populations.

KW - chronic tracheal cannulation

KW - CytoSorb

KW - hemoadsorption

KW - pediatric population

KW - pediatric sepsis

KW - pneumonia

KW - Sepsis

KW - septic shock

KW - severe laryngeal stenosis

UR - http://www.scopus.com/inward/record.url?scp=85060099964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060099964&partnerID=8YFLogxK

U2 - 10.1177/0391398818819953

DO - 10.1177/0391398818819953

M3 - Article

C2 - 30614343

AN - SCOPUS:85060099964

VL - 42

SP - 315

EP - 317

JO - International Journal of Artificial Organs

JF - International Journal of Artificial Organs

SN - 0391-3988

IS - 6

ER -